Review decision date: December 2014

Review decision: 

Following the recent surveillance review which checks  the need to update CG157, this guideline should not be updated at this time. This guideline will be checked again for update at its scheduled time point according to the methods described here

Next review date: June 2017

This clinical guideline offers best practice advice on the care of adults, children and young people with stage 4 or 5 chronic kidney disease (CKD) who have, or are at risk of, hyperphosphataemia.

People with stage 4 or 5 CKD often have high levels of phosphate in their blood; this is called hyperphosphataemia. When the kidneys are not working as well as they should, phosphate is not passed out of the body in the urine. Instead, it builds up in the blood and hyperphosphataemia develops.

  • National Institute for Health and Care Excellence (NICE) accreditation logo